168 related articles for article (PubMed ID: 33316109)
1. Fgf9 Negatively Regulates Bone Mass by Inhibiting Osteogenesis and Promoting Osteoclastogenesis Via MAPK and PI3K/AKT Signaling.
Tang L; Wu M; Lu S; Zhang H; Shen Y; Shen C; Liang H; Ge H; Ding X; Wang Z
J Bone Miner Res; 2021 Apr; 36(4):779-791. PubMed ID: 33316109
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-κB, MAPK and AKT signalling pathways.
Meng B; Wu D; Cheng Y; Huang P; Liu Y; Gan L; Liu C; Cao Y
Scand J Immunol; 2020 May; 91(5):e12874. PubMed ID: 32090353
[TBL] [Abstract][Full Text] [Related]
3. A point mutation in Fgf9 impedes joint interzone formation leading to multiple synostoses syndrome.
Tang L; Wu X; Zhang H; Lu S; Wu M; Shen C; Chen X; Wang Y; Wang W; Shen Y; Gu M; Ding X; Jin X; Fei J; Wang Z
Hum Mol Genet; 2017 Apr; 26(7):1280-1293. PubMed ID: 28169396
[TBL] [Abstract][Full Text] [Related]
4. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
5. Urokinase receptor mediates osteoclastogenesis via M-CSF release from osteoblasts and the c-Fms/PI3K/Akt/NF-κB pathway in osteoclasts.
Kalbasi Anaraki P; Patecki M; Tkachuk S; Kiyan Y; Haller H; Dumler I
J Bone Miner Res; 2015 Feb; 30(2):379-88. PubMed ID: 25196912
[TBL] [Abstract][Full Text] [Related]
6. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
7. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
8. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
9. Matrine derivate MASM uncovers a novel function for ribosomal protein S5 in osteoclastogenesis and postmenopausal osteoporosis.
Chen X; Zhi X; Cao L; Weng W; Pan P; Hu H; Liu C; Zhao Q; Zhou Q; Cui J; Su J
Cell Death Dis; 2017 Sep; 8(9):e3037. PubMed ID: 28880271
[TBL] [Abstract][Full Text] [Related]
10. Sclareol inhibits RANKL-induced osteoclastogenesis and promotes osteoblastogenesis through promoting CCN1 expression via repressing the MAPK pathway.
Li X; Wang Y; Li L; Zhou S; Zhao F
Cell Biol Toxicol; 2021 Dec; 37(6):849-871. PubMed ID: 33423118
[TBL] [Abstract][Full Text] [Related]
11. DZNep promotes mouse bone defect healing via enhancing both osteogenesis and osteoclastogenesis.
Cao X; He W; Rong K; Xu S; Chen Z; Liang Y; Han S; Zhou Y; Yang X; Ma H; Qin A; Zhao J
Stem Cell Res Ther; 2021 Dec; 12(1):605. PubMed ID: 34930462
[TBL] [Abstract][Full Text] [Related]
12. Garcinol suppresses RANKL-induced osteoclastogenesis and its underlying mechanism.
Jia Y; Jiang J; Lu X; Zhang T; Zhao K; Han W; Yang W; Qian Y
J Cell Physiol; 2019 May; 234(5):7498-7509. PubMed ID: 30471112
[TBL] [Abstract][Full Text] [Related]
13. Dual effect of WIN-34B on osteogenesis and osteoclastogenesis in cytokine-induced mesenchymal stem cells and bone marrow cells.
Seo BK; Ryu HK; Park YC; Huh JE; Baek YH
J Ethnopharmacol; 2016 Dec; 193():227-236. PubMed ID: 27401292
[TBL] [Abstract][Full Text] [Related]
14. Niloticin inhibits osteoclastogenesis by blocking RANKL-RANK interaction and suppressing the AKT, MAPK, and NF-κB signaling pathways.
Xu H; Jia Y; Li J; Huang X; Jiang L; Xiang T; Xie Y; Yang X; Liu T; Xiang Z; Sheng J
Biomed Pharmacother; 2022 May; 149():112902. PubMed ID: 35364377
[TBL] [Abstract][Full Text] [Related]
15. Diaporisoindole E inhibits RANKL-induced osteoclastogenesis via suppression of PI3K/AKT and MAPK signal pathways.
Hua P; Cui H; Xu J; Cai R; She Z; Gu Q
Phytomedicine; 2020 Aug; 75():153234. PubMed ID: 32510335
[TBL] [Abstract][Full Text] [Related]
16. l-tetrahydropalmatine suppresses osteoclastogenesis in vivo and in vitro via blocking RANK-TRAF6 interactions and inhibiting NF-κB and MAPK pathways.
Zhi X; Wang L; Chen H; Fang C; Cui J; Hu Y; Cao L; Weng W; Zhou Q; Qin L; Song H; Wang Y; Wang Y; Jiang H; Li X; Wang S; Chen X; Su J
J Cell Mol Med; 2020 Jan; 24(1):785-798. PubMed ID: 31725199
[TBL] [Abstract][Full Text] [Related]
17. FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans.
Yu H; Herbert BA; Valerio M; Yarborough L; Hsu LC; Argraves KM
Lipids Health Dis; 2015 Jul; 14():66. PubMed ID: 26138336
[TBL] [Abstract][Full Text] [Related]
18. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
[TBL] [Abstract][Full Text] [Related]
19. Suppression of osteoclastogenesis by N,N-dimethyl-D-erythro-sphingosine: a sphingosine kinase inhibition-independent action.
Kim HJ; Lee Y; Chang EJ; Kim HM; Hong SP; Lee ZH; Ryu J; Kim HH
Mol Pharmacol; 2007 Aug; 72(2):418-28. PubMed ID: 17504945
[TBL] [Abstract][Full Text] [Related]
20. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
